The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai is a clinical research site located in New York, New York, United States.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai has participated in 1 clinical trials.
Therapeutic areas: Multiple Sclerosis, Relapsing-Remitting.
Sponsors: Genzyme, a Sanofi Company.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai has 1 clinical trials on record. Their work covers Multiple Sclerosis, Relapsing-Remitting.
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.